HealthInvestor Executive Moves
Remember me:
HealthInvestor Executive moves The latest appointments in the independent healthcare industry

St Andrew's Healthcare: Julie Meikle

St Andrew’s Healthcare has appointed Julie Meikle as Director of Quality.

Julie was previously head of hospital inspection at the Care Quality Commission (CQC), where she has been for the last 15 years. Julie brings with her a wealth of experience, with the aim of helping to improve quality and performance across the organisation.

As director of quality, Julie will be focussed on providing an honest and open assessment for each service at St Andrew’s, including the Charity’s Child and Adolescence Mental Health Service and the Women’s unit, areas which are both undergoing substantial change.

Her appointment comes after St Andrew’s announced at the start of the year that it would be downsizing and reducing the number of inpatient beds, in order to consistently deliver high quality services with a focus on community care.

Katie Fisher, CEO of St Andrew’s said: “We’re delighted to have Julie on-board. Her extensive experience at the CQC and in the Mental Health sector will be enormously beneficial to us, as we aim to continuously improve care for our patients.

“This is a new role and one which help us deliver sustained improvement as part of our turnaround strategy.” 

Posted on: 29/05/2020

Latest news stories

The number of people considering paying for private treatment or health insurance has significantly increased since the Covid-19 outbreak, despite the impact of the pandemic on personal finances, according to new research.
Researchers from King’s Business School say that the care sector needs a new model of employment relations to tackle the challenges exposed by the Covid-19 crisis.
The number of deals announced in the global healthcare sector fell by 12% during the week ended June 28, according to GlobalData’s deals database
Health leaders have voiced concerns that the government’s messaging on pandemic mitigation is “clouded in confusion”.
Beckley Psytech has raised £3m of Series A funding to develop a pipeline of psychedelic drugs into licensed pharmaceutical medicines for treating psychiatric and neurological diseases.

HealthInvestor Feature

Consultant profile

Introducing: Kieran Mouser

As Senior Associate of the Finance and IT Practice at Compass Executives, Kieran is responsible for delivery into the investor and privately backed health and social care sectors, specialising in board level CFO, FD, IT and Programme Director mandates.

With a background in boutique finance executive recruitment, Kieran has a successful track record of delivering cross-functional searches for a broad range of clients, with notable placements across a range of assignments. Compass Executives
To find out more about Kieran, or to contact him about new opportunities, please contact or call 7860 355 504.

2019 InvestorPublishing.